Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women

CONTEXT: The ideal therapy for endometriosis (EM) and uterine fibroids (UFs) would suppress estrogenic drive to the endometrium and myometrium, while minimizing vasomotor symptoms and bone loss associated with current treatments. An integrated neurokinin-kisspeptin system involving substance P and n...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Endocrinol Metab
Hlavní autoři: Pawsey, Steve, Mills, Edouard Gregory, Ballantyne, Elizabeth, Donaldson, Kirsteen, Kerr, Mary, Trower, Mike, Dhillo, Waljit Singh
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Online Only Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8277204/
https://ncbi.nlm.nih.gov/pubmed/33624806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgab108
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky